|
|
Blood, 15 November 2006, Vol. 108, No. 10, pp. 3603-3610.
Prepublished online as a Blood First Edition Paper on July 20, 2006; DOI 10.1182/blood-2006-02-005272.
 Previous Article | Table of Contents | Next Article 
TRANSFUSION MEDICINE
Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers
Amy G. Tsai,
Pedro Cabrales,
Belur N. Manjula,
Seetharama A. Acharya,
Robert M. Winslow, and
Marcos Intaglietta
From the Department of Bioengineering, University of California, San Diego, La Jolla; La Jolla Bioengineering Institute, La Jolla, CA; the Department of Physiology and Biophysics and the Department of Medicine, Albert Einstein College of Medicine, Bronx, NY; and Sangart Inc, San Diego, CA.
Cell-free hemoglobin's (CFH) high affinity for nitric oxide (NO) could limit CFH's use as an oxygen-carrying blood replacement fluid because it scavenges NO, causing vasoconstriction and hypertension. However, the extent to which perivascular NO levels change following intravascular administration of hemoglobin (Hb) with different molecular dimensions correlates with vasoconstrictive responses in the microcirculation is unknown. The study objective was to determine vasoconstrictive effects following bolus infusions of (1)  cross-linked Hb; (2) polymerized bovine Hb; or (3) polyethylene glycol-decorated Hb (PEG-Hb), by measurements of in vivo microvessel diameter, blood flow, perivascular NO concentration, and systemic hemodynamic parameters. All CFHs caused reductions in perivascular NO levels, not correlated to microvascular responses. PEG-Hb (largest molecular volume) maintained blood flow, while the others caused vasoconstriction and reduced perfusion. All solutions increased mean arterial pressure due to vasoconstriction and blood volume expansion, except for PEG-Hb, which increased blood pressure due to blood volume expansion and maintenance of cardiac output. In conclusion, perivascular NO reduction is similar for all Hb solutions because NO binding affinities are similar; however, effects on vascular resistance are related to the type of molecular modification, molecular volume, and oxygen affinity.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Molecular volume and HBOC-induced vasoconstriction
- Andre F. Palmer
Blood 2006 108: 3231-3232.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
P. Cabrales, G. Sun, Y. Zhou, D. R. Harris, A. G. Tsai, M. Intaglietta, and A. F. Palmer
Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction
J Appl Physiol,
November 1, 2009;
107(5):
1548 - 1558.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. C. Irwin, B. Foreman, K. Morris, M. White, T. Sullivan, R. Jacobs, E. Monnet, T. Hackett, M. C. TissotvanPatot, K. L. Hamilton, et al.
Polymerized bovine hemoglobin decreases oxygen delivery during normoxia and acute hypoxia in the rat
Am J Physiol Heart Circ Physiol,
September 1, 2008;
295(3):
H1090 - H1099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Natanson, S. J. Kern, P. Lurie, S. M. Banks, and S. M. Wolfe
Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis
JAMA,
May 21, 2008;
299(19):
2304 - 2312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Y. Salazar Vazquez, P. Cabrales, A. G. Tsai, P. C. Johnson, and M. Intaglietta
Lowering of Blood Pressure by Increasing Hematocrit with Non Nitric Oxide Scavenging Red Blood Cells
Am. J. Respir. Cell Mol. Biol.,
February 1, 2008;
38(2):
135 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Sakai, A. Sato, K. Masuda, S. Takeoka, and E. Tsuchida
Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier
J. Biol. Chem.,
January 18, 2008;
283(3):
1508 - 1517.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
